Clinical TrialsSearch results
Number of results: 521
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- The evaluation of supportive care for hand-foot syndrome and stomatitis in patients with recurrent/ relapsed Müllerian carcinoma received chemotherapy of pegylated liposomal doxorubicin
- Recurrent/ Relapsed Müllerian carcinoma
- Japan Doxil study group
- 2009-05-18
Other
- the efficacy and safety of mycophenolate mofetil
- Noninfectious uveitis and scleritis
- Hiyama Tomona
- 2022-06-09
Other
- The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
- Far advanced or recurrent gastric cancer
- Department of Surgical Oncology The University of Tokyo
- 2008-08-30
Other
- The effect of Colestimide on the lowering activity of LDL-C and visceral fat in patients with hypercholesterolemia
- hypercholesterolemia
- The study group of the treatment for atherosclerotic diseases
- 2009-01-06
Other
- The assessment of the endothelial function using aldosterone receptor blockade in patients with hypertension
- essential hypertension
- Hiroshima Endothelial Function Study Group
- 2009-01-01
Other
- The Asia Primary Tube versus Trab (TVT) Study
- Open angle glaucoma including primary open angle glaucoma, pseudoexfoliative or pigmentary glaucoma.
- Hirooka Kazuyuki
- 2019-03-19
Other
- Study on the efficacy of octreotide acetate for cancer-related bowel obstruction
- cancer-related bowel obstruction
- University of Tsukuba
- 2006-11-14
Other
- Study on Prevention of Gastric Cancer by Early Detection of Helicobacter pylori Infection and Its Eradication(2nd-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan)
- Gastritis
- Second-Term Comprehensive 10-Years Strategy for Cancer Control (Ministry of Health and Welfare of Japan):Cancer Prevention
- 2007-01-31
Other
- Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)
- Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
- Nunomura Masaki
- 2022-09-28
Other
- Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer (DB-06)
- Advanced or Metastatic Breast Cancer
- Inoguchi Akihiro
- 2020-11-25